Nonselective (Propranolol) Beta-adrenergic Blocker

delayed repolarization syndromes. Mod Concepts Cardiovasc Dis 45: 117, 1976 28. Castellanos A, Salhanick L: Electrocardiographic patterns of procainamide cardiotoxicity. Am J Med Sci 253: 52, 1967 29. Epstein MA: Ventricular standstill during the intravenous procainamide treatment of ventricular tachycardia. Am Heart J 45: 890, 1953 30. Seiklos P, Chalme TM, Evans DW: Ventricular tachycardia after disopyramide. Lancet 1: 98, 1978 31. Chung EK: Beta-blockers in the treatment of disturbances in cardiac rhythm. In Beta-blockers Present Status and Future Prospects, edited by Schweizer W. Baltimore, University Park Press, 1974, p 221 32. Morganroth J, Michelson EL, Horowitz LN, Josephson ME, Pearlman AS, Dunkman WB: Limitations of routine long term electrocardiographic monitoring to assess ventricular ectopic frequency. Circulation 58: 408, 1978 33. Winkle RA: Antiarrhythmic drug effect mimicked by spontaneous variability of ventricular ectopy. Circulation 57: 116, 1978 34. Fabregas RA, Han J, Goel BG, Yoon MS: Facilitation of A-V nodal reciprocation by procainamide. Am Heart J 91: 460, 1976 35. Hoffman BF, Rosen MR, Wit AL: Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procainamide. B. Am Heart J 90: 117, 1975 36. Zipes DP, Troup PJ: New antiarrhythmic agents, amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil. Am J Cardiol 41: 1005, 1978 37. Elharrar V, Baum WE, Zipes DP: Effects of drugs on conduction delay and incidence of ventricular arrhythmias induced by acute coronary occlusion in dogs. Am J Cardiol 39: 544, 1977 38. Lown B: Sudden cardiac death: the major challenge confronting contemporary cardiology. Am J Cardiol 43: 313, 1979